Antibiotic resistance poses a significant threat to public health. The FDA collaborates with other agencies and organizations to promote the development of new antibiotics and alternative treatments. The agency supports the Antimicrobial Stewardship programs that aim to optimize the use of antibiotics, thereby reducing resistance and ensuring the effectiveness of existing treatments.
